The generic pharma player expects 2024 adjusted EPS of $2.40-$2.50 versus prior guidance of $2.30-$2.50 and consensus of $2.45.

WASHINGTON (AP) — The Supreme Court seemed skeptical Tuesday of allowing generic drug manufacturers to be sued in state court for a drug's design defects if federal officials approved the brand ...

The generic drug was launched in September. J.P. Morgan analyst Chris Schott reports that Crexont prescriptions are nearing 1,000 per week, with 964 recorded in the week of February 14.

Irvine-based Sicor Inc., for one, is readying by building a new factory in central Mexico where it plans to make generic versions of biotechs and other drugs. But Sicor and others may need more than ...

In recent years, the generic drug industry has been growing by leaps and bounds. Once seen as fringe players, generics now account for 65 percent of all U.S. prescriptions and post $59 billion in ...

Generic drug maker Mylan Inc is looking to buy Swedish rival Meda AB in a deal that would create a $23 billion pharmaceutical company, the Financial Times reported on Thursday.

Dr. Reddy’s Laboratories, a generic drug maker with U.S. headquarters in Princeton Junction, has won U.S. Food and Drug Administration approval to sell a generic version of Suboxone sublingual ...

News Leading Generic Drug Maker Slapped With €467 EU Antitrust Fine Teva described the EU regulator's decision as "extreme, untested and factually unsupported." November 01, 2024 at 11:09 AM 3 ...

WASHINGTON (AP) -- Profits for generic drug makers should scale new heights in coming years although that threat of an innovation drought and increased competition loom, a top industry analyst ...

The Supreme Court on Thursday ruled that makers of generic drugs cannot be sued for failing to warn consumers of the possible side effects of their products if they copy the exact warnings on the ...